DNA Ploidy and Local Recurrence in Breast Cancer
Author Information
Author(s): H. Beerman, B.A. Bonsing, M.J. van de Vijverl, J. Hermans, Ph.M. Kluin, R.J. Caspers, C.J.H. van de Velde, C.J. Cornelisse
Primary Institution: Leiden University Hospital
Hypothesis
Can DNA ploidy and clinico-pathological factors predict local recurrences after breast-conserving therapy?
Conclusion
The study suggests that local recurrences are often true recurrences rather than independently developed tumors, and that DNA-diploid tumors may be more resistant to radiotherapy.
Supporting Evidence
- 56% of local recurrences had the same DNA-aneuploid stemlines as their primary tumors.
- Half of the tumors that recurred had positive surgical margins.
- Ductal carcinoma in situ was significantly more common in recurrent tumors.
Takeaway
This study looked at breast cancer patients to see if certain tumor characteristics could help predict if their cancer would come back after treatment. They found that some tumors are more likely to come back than others.
Methodology
A retrospective study comparing 31 patients with local recurrence to 31 matched patients without recurrence, analyzing DNA ploidy and clinico-pathological factors.
Limitations
The study is retrospective and may not account for all variables influencing recurrence.
Participant Demographics
Patients were primarily women with primary breast carcinoma under 3 cm, treated between 1980 and 1988.
Statistical Information
P-Value
p<0.001
Confidence Interval
45%-75%
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website